Internal Medicine, Hematology & Oncology · Morgantown, WV
NPI
1013127638
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1 Medical Center Drive
Morgantown, WV, 26505
Phone (304) 293-4229
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
865 services
Medicare patients, 2024
248
Average age 71
Drug cost, 2024
$2.5M
458 prescriptions
Company payments, 2025
$60.47
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed Almubarak was code 99215 (office e&m - established), 557 times for 120 patients. In total Mohammed Almubarak billed 865 services in 12 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 557 | 120 | $104.87 | $58K |
| 99214 Office E&M - Established | Facility | 192 | 117 | $68.87 | $13K |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $105.01 | $2,415 |
| 99223 Hospital E&M - Initial | Facility | 20 | 19 | $138.97 | $2,779 |
| 99205 Office E&M - New | Facility | 19 | 19 | $139.43 | $2,649 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 15 | $95.33 | $1,525 |
| 99232 Hospital E&M - Subsequent | Facility | 14 | 14 | $63.33 | $887 |
By year: 2022 $52K for 590 services; 2023 $67K for 711 services; 2024 $83K for 865 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed Almubarak prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 89 prescriptions and refills. In total Mohammed Almubarak wrote 458 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 89 | 89 | Under 11 | $1.5M |
| Ondansetron Hcl Generic | 38 | 38 | 27 | $341 |
| Prochlorperazine Maleate Generic | 36 | 36 | 20 | $446 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 32 | 32 | 27 | $342 |
| Hydroxyurea Generic | 30 | 34 | Under 11 | $314 |
| Dexamethasone Generic | 28 | 28 | 19 | $400 |
| Prednisone Generic | 23 | 25 | 13 | $177 |
| Doxycycline Hyclate Generic | 14 | 14 | 12 | $60.14 |
| Methylprednisolone Generic | 13 | 13 | 11 | $94.42 |
| Lumakras Sotorasib | 12 | 12 | Under 11 | $253K |
| Rozlytrek Entrectinib | 12 | 12 | Under 11 | $354K |
| Gavreto Pralsetinib | 12 | 12 | Under 11 | $82K |
Brand drugs: 146 claims; generic drugs: 312 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed Almubarak $60.47 ($60.47 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $60.47.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $60.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.